Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5175)
All Articles published online
|
Feb 14, 2008 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sanal MG. The blind men ‘see’ the elephant-the many faces of fatty liver disease. World J Gastroenterol 2008; 14(6): 831-844 [PMID: 18240340 DOI: 10.3748/wjg.14.831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/831.htm |
| Number | Citing Articles |
| 1 |
Tolulope Eniola Omolekulo, Olugbenga Samuel Michael, Lawrence Aderemi Olatunji. Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid. Biomedicine & Pharmacotherapy 2019; 110: 869 doi: 10.1016/j.biopha.2018.12.036
|
| 2 |
Masaya Miyoshi, Akihiro Ogawa, Satoshi Higurashi, Yukio Kadooka. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. European Journal of Nutrition 2014; 53(2): 599 doi: 10.1007/s00394-013-0568-9
|
| 3 |
Zheng Sun, Mitchell A. Lazar. Dissociating fatty liver and diabetes. Trends in Endocrinology & Metabolism 2013; 24(1): 4 doi: 10.1016/j.tem.2012.09.005
|
| 4 |
Raghu Ramanathan, Karthikeyan Sivanesan. Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism. Chemico-Biological Interactions 2017; 273: 142 doi: 10.1016/j.cbi.2017.06.008
|
| 5 |
Natalia Belemets, Nazarii Kobyliak, Oleksandr Virchenko, Tetyana Falalyeyeva, Tsyryuk Olena, Petro Bodnar, Oleksiy Savchuk, Tetyana Galenova, Martin Caprnda, Luis Rodrigo, Lubomir Skladany, Delian Delev, Radka Opatrilova, Peter Kruzliak, Tetyana Beregova, Lyudmyla Ostapchenko. Effects of polyphenol compounds melanin on NAFLD/NASH prevention. Biomedicine & Pharmacotherapy 2017; 88: 267 doi: 10.1016/j.biopha.2017.01.028
|
| 6 |
Michał Kukla. Angiogenesis: a phenomenon which aggravates chronic liver disease progression. Hepatology International 2013; 7(1): 4 doi: 10.1007/s12072-012-9391-2
|
| 7 |
M.A. Hamed, R.E. Akhigbe, A.O. Aremu, A.F Odetayo. Zinc normalizes hepatic lipid handling via modulation of ADA/XO/UA pathway and caspase 3 signaling in highly active antiretroviral therapy-treated Wistar rats. Chemico-Biological Interactions 2022; 368: 110233 doi: 10.1016/j.cbi.2022.110233
|
| 8 |
Valerio Nobili, Arun J. Sanyal. Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. Journal of Gastroenterology 2012; 47(1): 29 doi: 10.1007/s00535-011-0467-x
|
| 9 |
Mustafa S Ascha, Mona L Ascha, Ibrahim A Hanouneh. Management of immunosuppressant agents following liver transplantation: Less is more. World Journal of Hepatology 2016; 8(3): 148-161 doi: 10.4254/wjh.v8.i3.148
|
| 10 |
A. Kuhla, T. Blei, R. Jaster, B. Vollmar. Aging Is Associated With a Shift of Fatty Metabolism Toward Lipogenesis. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011; (11): 1192 doi: 10.1093/gerona/glr124
|
| 11 |
Joan Oliva, Samuel W. French, Jun Li, Fawzia Bardag-Gorce. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Experimental and Molecular Pathology 2012; 93(1): 26 doi: 10.1016/j.yexmp.2012.03.006
|
| 12 |
Barbara J. Leonard. Nonalcoholic Fatty Liver Disease. Journal of Diagnostic Medical Sonography 2012; 28(1): 43 doi: 10.1177/8756479311429484
|
| 13 |
Mari Murakami, Kazuhiko Bessho, Sotaro Mushiake, Hiroki Kondou, Yoko Miyoshi, Keiichi Ozono. Major role of apolipoprotein B in cycloheximide‐induced acute hepatic steatosis in mice. Hepatology Research 2011; 41(5): 446 doi: 10.1111/j.1872-034X.2011.00791.x
|
| 14 |
Rani J Qasem, Jing Li, Hee Man Tang, Veron Browne, Claudia Mendez‐Garcia, Elizabeth Yablonski, Laura Pontiggia, Anil P D'Mello. Decreased liver triglyceride content in adult rats exposed to protein restriction during gestation and lactation: Role of hepatic triglyceride utilization. Clinical and Experimental Pharmacology and Physiology 2015; 42(4): 380 doi: 10.1111/1440-1681.12359
|
| 15 |
Tolulope Eniola Omolekulo, Emmanuel Damilare Areola, Olufunto Olayinka Badmus, Olugbenga Samuel Michael, Inkyeom Kim, Lawrence Aderemi Olatunji. Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen–progestin. Canadian Journal of Physiology and Pharmacology 2018; 96(11): 1092 doi: 10.1139/cjpp-2018-0231
|
| 16 |
Laia Bertran, Ailende Eigbefoh-Addeh, Marta Portillo-Carrasquer, Andrea Barrientos-Riosalido, Jessica Binetti, Carmen Aguilar, Javier Ugarte Chicote, Helena Bartra, Laura Artigas, Mireia Coma, Cristóbal Richart, Teresa Auguet. Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology. Biomedicines 2022; 10(6): 1315 doi: 10.3390/biomedicines10061315
|
| 17 |
Aldo Lagomarsino. Liver regeneration in nonalcoholic fatty liver disease. Medwave 2012; 12(11): e5559 doi: 10.5867/medwave.2012.11.5559
|
| 18 |
Carolina Huaman Samanez, Sandrine Caron, Olivier Briand, Hélène Dehondt, Isabelle Duplan, Folkert Kuipers, Nathalie Hennuyer, Véronique Clavey, Bart Staels. The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Archives of Physiology and Biochemistry 2012; 118(3): 102 doi: 10.3109/13813455.2012.683442
|
| 19 |
Madhusudana Girija Sanal, Shiv K. Sarin. Serum adipokine profile in Indian men with nonalcoholic steatohepatitis: Serum adiponectin is paradoxically decreased in lean vs. obese patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009; 3(4): 198 doi: 10.1016/j.dsx.2009.07.012
|
| 20 |
Keisuke Yamamoto, Kazuna Takahara, Seiichi Oyadomari, Tetsuya Okada, Takashi Sato, Akihiro Harada, Kazutoshi Mori, Ramanujan S. Hegde. Induction of Liver Steatosis and Lipid Droplet Formation in ATF6α-Knockout Mice Burdened with Pharmacological Endoplasmic Reticulum Stress. Molecular Biology of the Cell 2010; 21(17): 2975 doi: 10.1091/mbc.e09-02-0133
|
| 21 |
Yasunari Hiramine, Yasushi Imamura, Hirofumi Uto, Chihaya Koriyama, Masahisa Horiuchi, Makoto Oketani, Kaori Hosoyamada, Ken Kusano, Akio Ido, Hirohito Tsubouchi. Alcohol drinking patterns and the risk of fatty liver in Japanese men. Journal of Gastroenterology 2011; 46(4): 519 doi: 10.1007/s00535-010-0336-z
|
| 22 |
Roberto B Bazotte, Lorena G Silva, Fabiana PM Schiavon. Insulin resistance in the liver: Deficiency or excess of insulin?. Cell Cycle 2014; 13(16): 2494 doi: 10.4161/15384101.2014.947750
|
| 23 |
Naveena B. Janakiram, Altaf Mohammed, Li Qian, Chang-In Choi, Vernon E. Steele, Chinthalapally V. Rao. Chemopreventive Effects of RXR-Selective Rexinoid Bexarotene on Intestinal Neoplasia of ApcMin/+ Mice. Neoplasia 2012; 14(2): 159 doi: 10.1593/neo.111440
|
| 24 |
Gülsüm Özlem Elpek. Angiogenesis and liver fibrosis. World Journal of Hepatology 2015; 7(3): 377-391 doi: 10.4254/wjh.v7.i3.377
|
| 25 |
Madhusudana Girija Sanal. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?. World Journal of Gastroenterology 2015; 21(11): 3223-3231 doi: 10.3748/wjg.v21.i11.3223
|
| 26 |
Madhusudana Girija Sanal. Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis. Medical Hypotheses 2009; 72(3): 247 doi: 10.1016/j.mehy.2008.10.009
|
| 27 |
Dongmei Shi, Xi zhan, Xiaofeng Yu, Minglei Jia, Ying Zhang, Jianfeng Yao, Xiaona Hu, Zhijun Bao. Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-173
|
| 28 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2009; 16(2): 189 doi: 10.1097/MED.0b013e328329fcc2
|
| 29 |
Un Jung, Myung-Sook Choi. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2014; 15(4): 6184 doi: 10.3390/ijms15046184
|
| 30 |
Francesca M Trovato, Daniela Catalano, Adriana Garozzo, G Fabio Martines, Clara Pirri, Guglielmo M Trovato. ADV36 adipogenic adenovirus in human liver disease. World Journal of Gastroenterology 2014; 20(40): 14706-14716 doi: 10.3748/wjg.v20.i40.14706
|
| 31 |
Andreas S. Mueller, Sandra D. Klomann, Nicole M. Wolf, Sandra Schneider, Rupert Schmidt, Julia Spielmann, Gabriele Stangl, Klaus Eder, Josef Pallauf. Redox Regulation of Protein Tyrosine Phosphatase 1B by Manipulation of Dietary Selenium Affects the Triglyceride Concentration in Rat Liver. The Journal of Nutrition 2008; 138(12): 2328 doi: 10.3945/jn.108.089482
|
| 32 |
Jamie E. Mells, Ping P. Fu, Shvetank Sharma, Darin Olson, Lihong Cheng, Jeffrey A. Handy, Neeraj K. Saxena, Dan Sorescu, Frank A. Anania. Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(2): G225 doi: 10.1152/ajpgi.00274.2011
|
| 33 |
M. Schrader, N.A. Bonekamp, M. Islinger. Fission and proliferation of peroxisomes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012; 1822(9): 1343 doi: 10.1016/j.bbadis.2011.12.014
|
| 34 |
A. Kuhla, S. Hahn, A. Butschkau, S. Lange, A. Wree, B. Vollmar. Lifelong Caloric Restriction Reprograms Hepatic Fat Metabolism in Mice. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2014; 69(8): 915 doi: 10.1093/gerona/glt160
|
| 35 |
Madhusudana Girija Sanal. Is the change from NAFLD to MASLD driven by political correctness?. Journal of Hepatology 2024; 80(2): e74 doi: 10.1016/j.jhep.2023.08.027
|